GWPH stock is having its worst one-day fall in the past few months despite GW Pharmaceuticals (NASDAQ:GWPH) posting better-than-expected revenue from its flagship product, Epidiolex.
Solid EarningsDespite the troubles of the past few months, some companies in the cannabis industry have managed to perform well in the third quarter, and the latest company to exceed expectations is GW Pharmaceuticals. GW Pharmaceuticals is involved in producing medicines derived from CBD, and its most important product is Epidiolex, a CBD-infused medicine meant for epilepsy.
In its Q3 2019, the company managed to surpass expectations with ...
Read The Full Article On PotStockNews.com
Get the latest marijuana stock news, cannabis on stock news on PotStockNews
All content provided by Pot Stock News is subject to our Terms Of Use and Disclaimer.